KHIDI USAJan 10, 20221 min read8/30 - 9/6 North America Healthcare Market Weekly Report<Weekly Report>[1]Health Officials Advise Biden to Scale Back Covid-19 Booster Shots Plan For Now - The New York Times (nytimes.com)[2] https://news.google.com/covid19/map?hl=en-US&mid=%2Fm%2F02j71&gl=US&ceid=US%3Aen https://www.worldometers.info/coronavirus/?utm_campaign=instagramcoach1? [3]https://covid.cdc.gov/covid-data-tracker/#vaccinations [4] When Will the Delta Surge End? - The New York Times (nytimes.com)[5] The W.H.O. lists Mu as a ‘variant of interest.’ - The New York Times (nytimes.com)[6]Pandemic spurs rise of infections contracted at healthcare facilities | Healthcare Dive[7] Covid-19: Biden Pledges $2.7 Billion to Help Create ‘Arsenal of Vaccines For the World’ - The New York Times (nytimes.com)[8]FDA restarts distribution of Lilly's COVID-19 drug in 22 states | BioPharma Dive[9] Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims - The New York Times (nytimes.com)[10]Pfizer, Merck launch large new trials of oral COVID-19 drugs | Healthcare Dive[11] First Biogen, now the FDA: Congressional Democrats request agency records about Aduhelm's approval | FiercePharma[12]Medicare insolvency still expected by 2026, unchanged by COVID-19, trustees say | Healthcare Dive[13] With safety worries mounting, FDA limits who can take certain immune-regulating drugs | BioPharma Dive[14] As New Texas Abortion Ban Takes Effect, Providers Rush to Adjust - WSJ[15]Hospital lobby urges Congress to extend Medicare cut relief | Healthcare Dive[16]AHA presents Congress with laundry list of requests for budget reconciliation bill | Healthcare Dive
<Weekly Report>[1]Health Officials Advise Biden to Scale Back Covid-19 Booster Shots Plan For Now - The New York Times (nytimes.com)[2] https://news.google.com/covid19/map?hl=en-US&mid=%2Fm%2F02j71&gl=US&ceid=US%3Aen https://www.worldometers.info/coronavirus/?utm_campaign=instagramcoach1? [3]https://covid.cdc.gov/covid-data-tracker/#vaccinations [4] When Will the Delta Surge End? - The New York Times (nytimes.com)[5] The W.H.O. lists Mu as a ‘variant of interest.’ - The New York Times (nytimes.com)[6]Pandemic spurs rise of infections contracted at healthcare facilities | Healthcare Dive[7] Covid-19: Biden Pledges $2.7 Billion to Help Create ‘Arsenal of Vaccines For the World’ - The New York Times (nytimes.com)[8]FDA restarts distribution of Lilly's COVID-19 drug in 22 states | BioPharma Dive[9] Purdue Pharma Is Dissolved and Sacklers Pay $4.5 Billion to Settle Opioid Claims - The New York Times (nytimes.com)[10]Pfizer, Merck launch large new trials of oral COVID-19 drugs | Healthcare Dive[11] First Biogen, now the FDA: Congressional Democrats request agency records about Aduhelm's approval | FiercePharma[12]Medicare insolvency still expected by 2026, unchanged by COVID-19, trustees say | Healthcare Dive[13] With safety worries mounting, FDA limits who can take certain immune-regulating drugs | BioPharma Dive[14] As New Texas Abortion Ban Takes Effect, Providers Rush to Adjust - WSJ[15]Hospital lobby urges Congress to extend Medicare cut relief | Healthcare Dive[16]AHA presents Congress with laundry list of requests for budget reconciliation bill | Healthcare Dive
